undefined
EUTM file information

018250044

ACTONER


June 7, 2020

Trademark Summary

The trademark application ACTONER was filed by BRISEIS, S.A., a corporation established under the laws of the Kingdom of Spain (the "Applicant"). The application was published for oppositions on June 15, 2020, and it was registered by office on September 22, 2020 without any oppositions.

The application was filed in Spanish (English was selected as the second language).

The application claimed as seniority of the Kingdom of Spain trademark M1718803 and filed on August 27, 1992 which was accepted by the office.


Goods And Services

  • The mark was filed in class 3 with following description of goods:
    1. Non-medicated cosmetics and toiletry preparations
    2. Non-medicated dentifrices
    3. Mouthwashes, not for medical purposes
    4. Perfumery
    5. Ethereal oils
    6. Bleaching preparations and other substances for laundry use
    7. Cleaning and fragrancing preparations
    8. Polishing preparations
    9. Grease-removing preparations
    10. Abrasives.
  • The mark was filed in class 5 with following description of goods:
    1. Veterinary preparations
    2. Medical preparations, none being for use in relation to bone mass treatment
    3. Pharmaceuticals, none being for use in relation to bone mass treatment
    4. Chemical preparations for medical purposes, none being for use in relation to bone mass treatment
    5. Sanitary preparations for medical purposes
    6. Dietetic substances adapted for veterinary use
    7. Dietetic foods adapted for medical purposes
    8. Food for babies
    9. Dietary supplements for animals
    10. Dietary supplements for humans
    11. Plasters, materials for dressings
    12. Teeth filling material
    13. Chromatic alginate dental impression material
    14. Disinfectants
    15. Preparations for destroying noxious animals
    16. Herbicides
    17. Fungicides
    18. None of the above being in the form of tablets for oral consumption, pills for oral consumption or capsules for oral consumption, and none being for an osteoporosis treatment or for the treatment of Paget's disease.